RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties

Carcinogenesis

Volumn 25, Issue 2, 2004, Pages 157-167

  Horn, Elizabeth J ^a,b   Albor, Amador ^a   Liu, Yuangang ^a   El Hizawi, Sally ^a   Vanderbeek, Gretchen E ^a   Babcock, Melissa ^a   Bowden, G Tim ^c   Hennings, Henry ^d   Lozano, Guillermo ^e   Weinberg, Wendy C ^f   Kulesz Martin, Molly ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P53; TRANSCRIPTION FACTOR; TRIM32; TRIPARTITE MOTIF PROTEIN 32; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; EPIDERMIS CELL; EXPERIMENTAL NEOPLASM; GENETIC TRANSDUCTION; GENETICS; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LIMB GIRDLE MUSCULAR DYSTROPHY; METABOLISM; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN GRAFT; SKIN TRANSPLANTATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UBIQUITINATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; RNA, MESSENGER; SKIN NEOPLASMS; SKIN TRANSPLANTATION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES; ULTRAVIOLET RAYS;

EID: 10744221161     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh003     Document Type: Article

References (43)

1. Reymond,A., Meroni,G., Fantozzi,A. et al. (2001) The tripartite motif family identifies cell compartments. EMBO J., 20, 2140-2151.
2. Urano,T., Saito,T., Tsukui,T., Fujita,M., Hosoi,T., Muramatsu,M., Ouchi,Y. and Inoue,S. (2002) Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature, 417, 871-875.
3. Frosk,P., Weiler,T., Nylen,E., Sudha,T., Greenberg,C.R., Morgan,K., Fujiwara,T.M. and Wrogemann,K. (2002) Limb-girdle muscular dystrophy Type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am. J. Hum. Genet., 70, 663-672.
4. Joazeiro,C.A. and Weissman,A.M. (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell, 102, 549-552.
5. Lupas,A. (1996) Coiled coils: new structures and new functions. Trends Biochem. Sci., 21, 375-382.
6. Slack,F.J. and Ruvkun,G. (1998) A novel repeat domain that is often associated with RING finger and B-box motifs. Trends Biochem. Sci., 23, 474-475.
7. Trockenbacher,A., Suckow,V., Foerster,J., Winter,J., Krauss,S., Ropers,H.H., Schneider,R. and Schweiger,S. (2001) MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nature Genet., 29, 287-294.
8. Kulesz-Martin,M.F., Penetrante,R. and East,C.J. (1988) Benign and malignant tumor stages in a mouse keratinocyte cell line treated with 7,12-dimethylbenz[α]anthracene in vitro. Carcinogenesis, 9, 171-174.
9. Liu,Y. and Kulesz-Martin,M.F. (1998) Altered gene expression in a clonal epidermal cell model of carcinogenesis identified by RNA differential display. Carcinogenesis, 19, 683-686.
10. O Albor,A., Kaku,S. and Kulesz-Martin,M.F. (1998) Wild type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for the gain of function in mutants. Cancer Res., 58, 2091-2094.
11. Kulesz-Martin,M.F., Yoshida,M., Prestine,L., Yuspa,S.H. and Bertram,J.S. (1985) Mouse cell clones for improved quantitation of carcinogen-induced altered differentiation. Carcinogenesis, 6, 1245-1254.
12. Weinberg,W.C., Azzoli,C.G., Kadiwar,N. and Yuspa,S.H. (1994) P53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-ras(Ha) oncogene. Cancer Res., 54, 5584-5592.
13. Liu,G., McDonnell,T.J., Montes de Oca Luna,R., Kapoor,M., Mims,B., El-Naggar,A.K. and Lozano,G. (2000) High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc. Natl Acad. Sci. USA, 97, 4174-4179.
14. Rathbun,R.K., Christianson,T.A., Faulkner,G.R., Jones,G., Keeble,W., O'Dwyer,M. and Bagby,G.C. (2000) Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood, 96, 4204-4211.
15. Schneider,B.L., Kulesz-Martin,M. and Bowden,G.T. (1995) Induced terminal differentiation and tumorigenic suppression in murine keratinocyte somatic-cell hybrids. Mol. Carcinogen., 13, 6-14.
16. Han,K.-A. and Kulesz-Martin,M. (1992) Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation. Cancer Res., 52, 749-753.
17. Wang,Z., Liu,Y., Mori,M. and Kulesz-Martin,M. (2002) Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates. Carcinogenesis, 23, 635-643.
18. Fridell,R.A., Harding,L.S., Bogerd,H.P. and Cullen,B.R. (1995) Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology, 209, 347-357.
19. Kulesz-Martin,M., Kilkenny,A.E., Holbrook,K.A., Digernes,V. and Yuspa,S.H. (1983) Properties of carcinogen altered mouse epidermal cells resistant to calcium-induced terminal differentiation. Carcinogenesis, 4, 1367-1377.
20. Kilkenny,A.E., Morgan,D., Spangler,E.F. and Yuspa,S.H. (1985) Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse keratinocytes. Cancer Res., 45, 2219-2225.
21. Kawamura,H., Strickland,J.E. and Yuspa,S.H. (1985) Association of resistance to terminal differentiation with initiation of carcinogenesis in adult mouse epidermal cells. Cancer Res., 45, 2748-2752.
22. Burg,G. (2000) Atlas of Cancer of the Skin. Churchill Livingstone, Philadelphia.
23. Levine,A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
24. Zhuang,L., Wang,B. and Sauder,D.N. (2000) Molecular mechanism of ultraviolet-induced keratinocyte apoptosis. J. Interf. Cytok. Res., 20, 445-454.
25. Zhuang,L., Wang,B., Shinder,G.A., Shivji,G.M., Mak,T.W. and Sauder,D.N. (1999) TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J. Immunol., 162, 1440-1447.
26. Ziegler,A., Jonason,A.S., Leffell,D.J., Simon,J.A., Sharma,H.W., Kimmelman,J., Remington,L., Jacks,T. and Brash,D.E. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.
27. Okamoto,H., Mizuno,K., Itoh,T., Tanaka,K. and Horio,T. (1999) Evaluation of apoptotic cells induced by ultraviolet light B radiation in epidermal sheets stained by the TUNEL technique. J. Invest. Dermatol., 113, 802-807.
28. Cotton,J. and Spandau,D.F. (1997) Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiat. Res., 147,148-155.
29. Tsai,J.C., Feingold,K.R., Crumrine,D., Wood,L.C., Grunfeld,C. and Elias,P.M. (1994) Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis. Arch. Dermatol. Res., 286, 242-248.
30. Oxholm,A., Oxholm,P., Staberg,B. and Bendtzen,K. (1988) Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br. J. Dermatol., 118, 369-376.
31. Campbell,C., Hultman,S., Cairns,B., DeSerres,S. and Meyer,A. (2003) Green fluorescent protein-adenoviral construct as a model for transient gene therapy for human cultured keratinocytes in an athymic mouse model. J. Trauma-Inj. Infect. Crit. Care, 54, 72-79.
32. Boukamp,P., Stanbridge,E.J., Foo,D.Y., Cerutti,P.A. and Fusenig,N.E. (1990) c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res., 50, 2840-2847.
33. Elder,D.E., Elenitsas,R., Johnson,B.L.,Jr, Ioffreda,M., Miller,J.J. and Miller,O.F.,III (1999) Synopsis and Atlas of Lever's Histopathology of the Skin. Lippincott Williams & Wilkins, Philadelphia, PA.
34. Gat,U., DasGupta,R., Degenstein,L. and Fuchs,E. (1998) De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell, 95, 605-614.
35. Megosh,L., Gilmour,S.K., Rosson,D., Soler,A.P., Blessing,M., Sawicki,J.A. and O'Brien,T.G. (1995) Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res., 55, 4205-4209.
36. Hansen,L.S., Coggle,J.E., Wells,J. and Charles,M.W. (1984) The influence of the hair cycle on the thickness of mouse skin. Anatom. Rec., 210, 569-573.
37. Chan,F.K., Siegel,R.M. and Lenardo,M.J. (2000) Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity, 419-422.
38. Assefa,Z., Vantieghem,A., Garmyn,M., Declercq,W., Vandenabeele,P., Vandenheede,J.R., Bouillon,R., Merlevede,W. and Agostinis,P. (2000) p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J. Biol. Chem., 275, 21416-21421.
39. Seitz,C.S., Freiberg,R.A., Hinata,K. and Khavari,P.A. (2000) NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest, 105, 253-260.
40. Dajee,M., Lazarov,M., Zhang,J.Y. et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature., 421, 639-643.
41. Baghdiguian,S., Martin,M., Richard,I. et al. (1999) Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nature Med., 5, 503-511.
42. Lorick,K.L., Jensen,J.P., Fang,S., Ong,A.M., Hatakeyama,S. and Weissman,A.M. (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. USA, 96, 11364-11369.
43. Duprez,E., Saurin,A.J., Desterro,J.M., Lallemand-Breitenbach,V., Howe,K., Boddy,M.N., Solomon,E., de The,H., Hay,R.T. and Freemont,P.S. (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci., 112, 381-393.